Forums – margaretrogers57 – Melanoma Research Foundation

Forum Topics Started

Viewing 15 topics - 1 through 15 (of 24 total)

- TOPIC
- revlimid/sorafenib for treatment of metastic ocular melanoma
  Started by: margaretrogers57 Ocular Melanoma Community
- 1
- 3
- lak
  
  12 years, 2 months ago
- c-met trial
  Started by: margaretrogers57 General Melanoma Community
- 1
- 3
- ThatHomeschoolDad
  
  12 years, 9 months ago
- ly2875358
  Started by: margaretrogers57 Ocular Melanoma Community
- 1
- 3
- ThatHomeschoolDad
  
  12 years, 10 months ago
- ly2875358
  Started by: margaretrogers57 Ocular Melanoma Community
- 2
- 6
- margaretrogers57
  
  12 years, 10 months ago
- Anti-pd-1 and bilirubin and alkaline phospate levels.
  Started by: margaretrogers57 General Melanoma Community
- 2
- 6
- margaretrogers57
  
  13 years ago
- Anti-pd-1 and bilirubin and alkaline phospate levels.
  Started by: margaretrogers57 General Melanoma Community
- 0
- 0
- margaretrogers57
  
  13 years ago
- anti-pd-1
  Started by: margaretrogers57 Ocular Melanoma Community
- 4
- 18
- lak
  
  13 years, 1 month ago
- pd-1
  Started by: margaretrogers57 Ocular Melanoma Community
- 0
- 0
- margaretrogers57
  
  13 years, 3 months ago
- chemoembolization
  Started by: margaretrogers57 General Melanoma Community
- 3
- 12
- margaretrogers57
  
  13 years, 4 months ago
- anti-pd-1 trials
  Started by: margaretrogers57 Ocular Melanoma Community
- 2
- 6
- margaretrogers57
  
  13 years, 4 months ago
- rash from selumetinib
  Started by: margaretrogers57 General Melanoma Community
- 0
- 0
- margaretrogers57
  
  13 years, 5 months ago
- rash from selumetinib
  Started by: margaretrogers57 General Melanoma Community
- 0
- 0
- margaretrogers57
  
  13 years, 5 months ago
- pd-L1
  Started by: margaretrogers57 Ocular Melanoma Community
- 0
- 0
- margaretrogers57
  
  13 years, 5 months ago
- pd-L1
  Started by: margaretrogers57 Ocular Melanoma Community
- 0
- 0
- margaretrogers57
  
  13 years, 5 months ago

Viewing 15 topics - 1 through 15 (of 24 total)